Perrigo Company plc Increase (Decrease) in Other Noncurrent Liabilities
Perrigo Company plc (PRGO) reported Increase (Decrease) in Other Noncurrent Liabilities of $2.60 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-05
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-27 was -$100.00K, a 103.45% decline year-over-year.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-28 was $2.70M.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$11.50M.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-27 was $8.90M.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$200.00K.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Perrigo Company plc increase (decrease) in other noncurrent liabilities for fiscal 2023 was $7.60M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-27 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.60M 10-Q · filed 2026-08-05 | -$8.90M derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $2.70M 10-Q · filed 2026-05-06 | -$8.80M derived: sum of 2 quarters · filed 2026-05-06 | $100.00K derived: sum of 3 quarters · filed 2026-05-06 | $3.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.60M derived: sum of 2 quarters · filed 2026-02-26 | $300.00K derived: sum of 3 quarters · filed 2026-08-05 | -$200.00K 10-K · filed 2026-02-26 |
| 2025-09-27 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.80M derived: sum of 2 quarters · filed 2026-08-05 | $11.30M 10-Q · filed 2025-11-05 | -$3.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.40M 10-Q · filed 2026-08-05 | -$12.50M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-03-29 | -$500.00K 10-Q · filed 2026-05-06 | -$15.40M derived: sum of 2 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-09-28 | $14.90M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $7.60M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |